Adsorption and folding dynamics of MPER of HIV-1 gp41 in the presence of dpc micelle

Proteins: Structure, Function and Bioinformatics

Volumn 81, Issue 6, 2013, Pages 933-944

  Hartono, Yossa Dwi ^a   Mun, Yip Yew ^a   Zhang, Dawei ^a  

^a Nanyang Technological University   (Singapore)

Author keywords

AHBC; Charge variation; DPC micelle; MPER adsorption; MPER folding

Indexed keywords

GLYCOPROTEIN 41; UNCLASSIFIED DRUG; VIRUS GLYCOPROTEIN;

ADSORPTION; ARTICLE; HUMAN IMMUNODEFICIENCY VIRUS 1; MEMBRANE PROXIMAL ECTODOMAIN REGION; MICELLE; MOLECULAR DYNAMICS; NONHUMAN; NUCLEAR MAGNETIC RESONANCE; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN FOLDING; PROTEIN INTERACTION; PROTEIN STRUCTURE;

ADSORPTION; HIV ENVELOPE PROTEIN GP41; HIV INFECTIONS; HIV-1; HOST-PATHOGEN INTERACTIONS; HUMANS; MEMBRANE FUSION; MICELLES; MODELS, MOLECULAR; PHOSPHATIDYLCHOLINES; PROTEIN FOLDING; PROTEIN STRUCTURE, SECONDARY; PROTEIN STRUCTURE, TERTIARY;

HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 84878157216     PISSN: 08873585     EISSN: 10970134     Source Type: Journal    
DOI: 10.1002/prot.24256     Document Type: Article

References (50)

1. Feng F, Broder CC, Kennedy PE, Berger EA. HIV-1 entry co-factor: functional cDNA cloning of a seven-transmembrane, G protein-coupled receptor. Science 1996; 272: 872-877.
2. Melikyan GB, Markosyan RM, Hemmati H, Delmedico MK, Lambert DM, Cohen FS. Evidence that the transition of HIV-1 gp41 into a six-helix bundle, not the bundle configuration, induces membrane fusion. J Cell Biol 2000; 151: 413-423.
3. Sabin C, Corti D, Buzon V, Seaman MS, Lutje Hulsik D, Hinz A, Vanzetta F, Agatic G, Silacci C, Mainetti L, Scarlatti G, Sallusto F, Weiss R, Lanzavecchia A, Weissenhorn W. Crystal structure and size-dependent neutralization properties of HK20, a human monoclonal antibody binding to the highly conserved heptad repeat 1 of gp41. PLoS Pathog 2010; 6: e1001195.
4. Luftig MA, Mattu M, Di Giovine P, Geleziunas R, Hrin R, Barbato G, Bianchi E, Miller MD, Pessi A, Carfí A. Structural basis for HIV-1 neutralization by a gp41 fusion intermediate-directed antibody. Nat Struct Mol Biol 2006; 13: 740-747.
5. Hartono YD, Lazim R, Yip YM, Zhang D. Computational study of bindings of HK20 Fab and D5 Fab to HIV-1 gp41. Bioorg Med Chem Lett 2012; 22: 1695-1700.
6. Liu S, Wu S, Jiang S. HIV entry inhibitors targeting gp41: from polypeptides to small-molecule compounds. Curr Pharm Des 2007; 13: 143-162.
7. Lee-Huang S, Maiorov V, Huang PL, Ng A, Lee HC, Chang Y, Kallenbach N, Huang PL, Chen H. Structural and functional modeling of human lysozyme reveals a unique nonapeptide, HL9, with anti-HIV activity. Biochemistry 2005; 44: 4648-4655.
8. Hartono YD, Lee AN, Lee-Huang S, Zhang D. Computational study of bindings of HL9, a nonapeptide fragment of human lysozyme, to HIV-1 fusion protein gp41. Bioorg Med Chem Lett 2011; 21: 1607-1611.
9. Muster T, Steindl F, Purtscher M, Trkola A, Klima A, Himmler G, Ruker F, Katinger H. A conserved neutralizing epitope on gp41 of human immunodeficiency virus type 1. J Virol 2011; 67: 6642-6647.
10. Zwick MB, Labrijn AF, Wang M, Spenlehauer C, Saphire EO, Binley JM, Moore JP, Stiegler G, Katinger H, Burton DR, Parren PW. Broadly neutralizing antibodies targeted to the membrane-proximal external region of human immunodeficiency virus type 1 glyco-protein gp41. J Virol 2001; 75: 10892-10905.
11. Zwick MB, Wang M, Poignard P, Stiegler G, Katinger H, Burton DR, Parren PW. Neutralization synergy of human immunodeficiency virus type 1 primary isolates by cocktails of broadly neutralizing antibodies. J Virol 2001; 75: 12198-12208.
12. Montero M, van Houten NE, Wang X, Scott JK. The membrane-proximal external region of the human immunodeficiency virus type 1 envelope: dominant site of antibody neutralization and target for vaccine design. Microbiol Mol Biol Rev 2008; 72: 54.
13. Purtscher M, Trkola A, Gruber G, Buchacher A, Predl R, Steindl F, Tauer C, Berger R, Barrett N, Jungbauer A, Katinger H. A broadly neutralizing human monoclonal antibody against gp41 of human immunodeficiency virus type 1. AIDS Res Hum Retrovir 1994; 10: 1651-1658.
14. Kilby JM, Hopkins S, Venetta TM, DiMassimo B, Cloud GA, Lee JY, Alldredge L, Hunter E, Lambert D, Bolognesi D, Matthews T, Johnson MR, Nowak MA, Shaw GM, Saag MS. Potent suppression of HIV-1 replication in humans by T-20, a peptide inhibitor of gp41-mediated virus entry. Nat Med 1998; 4: 1302-1307.
15. Lawless MK, Barney S, Guthrie KI, Bucy TB, Petteway SR, Jr, Merutka G. HIV-1 membrane fusion mechanism: structural studies of the interactions between biologically-active peptides from gp41. Biochemistry 1996; 35: 13697-13708.
16. Salzwedel K, West JT, Hunter E. A conserved tryptophan-rich motif in the membrane-proximal region of the human immunodeficiency virus type 1 gp41 ectodomain is important for Env-mediated fusion and virus infectivity. J Virol 1999; 73: 2469-2480.
17. Bellamy-McIntyre AK, Lay CS, Bar S, Maerz AL, Talbo GH, Drummer HE, Poumbourios P. Functional links between the fusion peptide-proximal polar segment and membrane-proximal region of human immunodeficiency virus type 1 gp41 in distinct phases of membrane fusion. J Biol Chem 2007; 282: 23104-23116.
18. Munoz-Barroso I, Salzwedel K, Hunter E, Blumenthal R. Role of the membrane-proximal domain in the initial stages of human immunodeficiency virus type 1 envelope glycoprotein-mediated membrane fusion. J Virol 1999; 73: 6089-6092.
19. Poumbourios P, Ahmar W, McPhee DA, Kemp BE. Determinants of human immunodeficiency virus type 1 envelope glycoprotein oligomeric structure. J Virol 1995; 69: 1209-1218.
20. Zwick MB, Jensen R, Church S, Wang M, Stiegler G, Kunert R, Katinger H, Burton DR. Anti-human immunodeficiency virus type 1 (HIV-1) antibodies 2F5 and 4E10 require surprisingly few crucial residues in the membrane-proximal external region of glycoprotein gp41 to neutralize HIV-1. J Virol 2005; 79: 1252-1261.
21. Saez-Cirion A, Gomara MJ, Agirre A, Nieva JL. Pre-transmembrane sequence of Ebola glycoprotein. Interfacial hydrophobicity distribution and interaction with membranes. FEBS Lett 2003; 533: 47-53.
22. Moreno MR, Pascual R, Villalain J. Identification of membrane-active regions of the HIV-1 envelope glycoprotein gp41 using a 15-mer gp41-peptide scan. Biochim Biophys Acta 2004; 1661: 97-105.
23. Suarez T, Gallaher WR, Agirre A, Goni FM, Nieva JL. Membrane interface-interacting sequences within the ectodomain of the human immunodeficiency virus type 1 envelope glycoprotein: putative role during viral fusion. J Virol 2000; 74: 8038-8047.
24. Suarez T, Nir S, Goni FM, Saez-Cirion A, Nieva JL. The pre-transmembrane region of the human immunodeficiency virus type-1 glycoprotein: a novel fusogenic sequence. FEBS Lett 2000; 477: 145-149.
25. Chan DC, Fass D, Berger JM, Kim PS. Core structure of gp41 from the HIV envelope glycoprotein. Cell 1997; 89: 263-273.
26. Buzon V, Natrajan G, Schibli D, Campelo F, Kozlov MM, Weissenhorn W. Crystal structure of HIV-1 gp41 including both fusion peptide and membrane proximal external regions. PLoS Pathog 2010; 6: e1000880.
27. Shi W, Bohon J, Han DP, Habte H, Qin Y, Cho MW, Chance MR. Structural characterization of HIV gp41 with the membrane-proximal external region. J Biol Chem 2010; 285: 24290-2429.
28. Tan K, Liu J, Wang J, Shen S, Lu M. Atomic structure of a thermostable subdomain of HIV-1 gp41. Proc Natl Acad Sci USA 1997; 94: 12303-12308.
29. Weissenhorn W, Dessen A, Harrison SC, Skehel JJ, Wiley DC. Atomic structure of the ectodomain from HIV-1 gp41. Nature 1997; 387: 426-430.
30. Ofek G, Tang M, Sambor A, Katinger H, Mascola JR, Wyatt R, Kwong PD. Structure and mechanistic analysis of the anti-human immunodeficiency virus type 1 antibody 2F5 in complex with its gp41 epitope. J Virol 2004; 78: 10724-10737.
31. Pai EF, Klein MH, Chong P, Pedyczak A. Fab-epitope complex from the HIV-1 cross-neutralizing monoclonal antibody 2F5. US patent WO-00/61618; 2000.
32. Nelson JD, Brunel FM, Jensen R, Crooks ET, Cardoso RM, Wang M, Hessell A, Wilson IA, Binley JM, Dawson PE, Burton DR, Zwick MB. An affinity-enhanced neutralizing antibody against the membrane-proximal external region of human immunodeficiency virus type 1 gp41 recognizes an epitope between those of 2F5 and 4E10. J Virol 2007; 81: 4033-4043.
33. Sun ZY, Oh KJ, Kim M, Yu J, Brusic V, Song L, Qiao Z, Wang JH, Wagner G, Reinherz EL. HIV-1 Broadly neutralizing antibody extracts its epitope from a kinked gp41 ectodomain region on the viral membrane. Immunity 2008; 28: 52-63.
34. 20 in Thioredoxin. Biophys J 2008; 95: 1080.
35. Mei Y, Ji CG, Zhang JZH. A new quantum method for electrostatic solvation energy of protein. J Chem Phys 2006; 125: 94906.
36. Zhang DW, Zhang JZH. Molecular fractionation with conjugate caps for full quantum mechanical calculation of protein-molecule interaction energy. J Chem Phys 2003; 119: 3599.
37. Duan LL, Mei Y, Zhang QG, Zhang JZH. Intra-protein hydrogen bonding is dynamically stabilized by electronic polarization. J Chem Phys 2009; 130: 115102.
38. 2+ complex in the catalytic core domain of HIV-1 integrase. J Chem Phys 2010; 132: 131101.
39. Wei C, Tung D, Yip YM, Mei Y, Zhang D. Communication: the electrostatic polarization is essential to differentiate the helical propensity in polyalanine mutants. J Chem Phys 2011; 134: 171101.
40. Xu Z, Lazim R, Sun T, Mei Y, Zhang D. Solvent effect on the folding dynamics and structure of E6-associated protein characterized from ab initio protein folding simulations. J Chem Phys 2012; 136: 135102.
41. Mei Y, Wei C, Yip YM, Ho CY, Zhang JZH, Zhang D. Folding and thermodynamic studies of Trp-cage based on polarized force field. Theor Chem Acc 2012; 131: 1168.
42. Duan LL, Mei Y, Zhang D, Zhang QG, Zhang JZH. Folding of a helix at room temperature is critically aided by electrostatic polarization of intraprotein hydrogen bonds. J Am Chem Soc 2010; 132: 11159-11164.
43. Wei C, Mei Y, Zhang D. Theoretical study on the HIV-1 integrase-5CITEP complex based on polarized force fields. Chem Phys Lett 2010; 495: 121-124.
44. Tong Y, Mei Y, Li YL, Ji CG, Zhang JZH. Electrostatic polarization makes a substantial contribution to the free energy of avidin-biotin binding. J Am Chem Soc 2010; 132: 5137-5142.
45. Case DA, Darden TA, Cheatham TE, III, Simmerling CL, Wang J, Duke RE, Luo R, Merz KM, Pearlman DA, Crowley M, Walker RC, Zhang W, Wang B, Hayik S, Roitberg A, Seabra G, Wong KF, Paesani F, Wu X, Brozell S, Tsui V, Gohlke H, Yang L, Tan C, Mongan J, Hornak V, Cui G, Beroza P, Mathews DH, Schafmeister C, Ross WS, Kollman AP AMBER 9. San Francisco. University of California; 2006.
46. Hornak V, Abel R, Okur A, Strockbine B, Roitberg A. Comparison of multiple Amber force fields and development of improved protein backbone parameters. Proteins 2006; 65: 712-725.
47. Duan Y, Wu C, Chowdhury S, Lee MC, Xiong G, Zhang W, Yang R, Cieplak P, Luo R, Lee TJ. A point-charge force field for molecular mechanics simulations of proteins based on condensed-phase quantum mechanical calculations. Comput Chem 2003; 24: 1999-2012.
48. Jorgensen WL, Chandrasekhar J, Madura JD, Impey RW, Klein ML. Comparison of simple potential functions for simulating liquid water. J Chem Phys 1983; 79: 926-935.
49. Ryckaert J, Ciccotti G, Berendsen H. Numerical integration of the cartesian equations of motion of a system with constraints: molecular dynamics of n-Alkanes. Comput Phys 1977; 23: 327-341.
50. Humphrey W, Dalke A, Schulten K. VMD: visual molecular dynamics. J Mol Graph 1996; 14: 33-38, 27-28.